The enzymatic cascade triggered by activation of plasminogen has been impli
cated in a variety of normal and pathologic events, such as fibrinolysis, w
ound healing, tissue remodeling, embryogenesis, and the invasion and spread
of transformed tumor cells. Recent data established that the Ca2+- and pho
spholipid-binding protein, annexin II heterotetramer (AIIt) binds tissue-ty
pe plasminogen activator (tPA), plasminogen, and plasmin, and dramatically
stimulates the tPA-dependent conversion of plasminogen to plasmin in vitro.
Interestingly, the binding of plasmin to AIIt can inhibit the activity of
the enzyme, suggesting that plasmin bound to the cell surface is regulated
by AIIt. The existing experimental evidence suggests that AIIt is the key p
hysiological receptor for plasminogen on the extracellular surface of endot
helial cells. (Trends Cardiovasc Med 1999;9:92-102). (C) 1999, Elsevier Sci
ence Inc.